Covers the 15 August 2025 FDA approval of Tonix Pharmaceuticals' Tonmya (TNX-102 SL sublingual cyclobenzaprine) - the first new Read the full review Neuroscience 1 May 2026 Dihexa for Multiple Sclerosis (MS): Cognitive Impairment, Remyelination & the 2026 UK Review Can Dihexa help MS cognitive impairment or remyelination
We chose to invest in both the Lipofirm Pro and Med systems because of their FDA approval, clinical research, and the scientific evidence supporting radio frequency treatments
Using a target trial emulation framework, researchers analyzed Truveta Data and compared adults with alcohol use disorder (AUD) and either type 2 diabetes or obesity who started a newer GLP-1 RA (semaglutide, tirzepatide) to similar individuals starting alternative medications
This talk is important to know the good and bad of Ozempic for you
BPC-157 accelerates healing of the gut lining and supports tissue regeneration
Certain foods seem to encourage belly fat